These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 10213593

  • 1. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
    Felix JP, Bugianesi RM, Schmalhofer WA, Borris R, Goetz MA, Hensens OD, Bao JM, Kayser F, Parsons WH, Rupprecht K, Garcia ML, Kaczorowski GJ, Slaughter RS.
    Biochemistry; 1999 Apr 20; 38(16):4922-30. PubMed ID: 10213593
    [Abstract] [Full Text] [Related]

  • 2. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
    Koo GC, Blake JT, Shah K, Staruch MJ, Dumont F, Wunderler D, Sanchez M, McManus OB, Sirotina-Meisher A, Fischer P, Boltz RC, Goetz MA, Baker R, Bao J, Kayser F, Rupprecht KM, Parsons WH, Tong XC, Ita IE, Pivnichny J, Vincent S, Cunningham P, Hora D, Feeney W, Kaczorowski G.
    Cell Immunol; 1999 Nov 01; 197(2):99-107. PubMed ID: 10607427
    [Abstract] [Full Text] [Related]

  • 3. Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
    Bao J, Miao S, Kayser F, Kotliar AJ, Baker RK, Doss GA, Felix JP, Bugianesi RM, Slaughter RS, Kaczorowski GJ, Garcia ML, Ha SN, Castonguay L, Koo GC, Shah K, Springer MS, Staruch MJ, Parsons WH, Rupprecht KM.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):447-51. PubMed ID: 15603971
    [Abstract] [Full Text] [Related]

  • 4. Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.
    Helms LM, Felix JP, Bugianesi RM, Garcia ML, Stevens S, Leonard RJ, Knaus HG, Koch R, Wanner SG, Kaczorowski GJ, Slaughter RS.
    Biochemistry; 1997 Mar 25; 36(12):3737-44. PubMed ID: 9132027
    [Abstract] [Full Text] [Related]

  • 5. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
    Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W.
    J Immunol; 1997 Jun 01; 158(11):5120-8. PubMed ID: 9164927
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H, Grissmer S.
    Toxicon; 2004 Jun 15; 43(8):951-60. PubMed ID: 15208028
    [Abstract] [Full Text] [Related]

  • 7. Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties.
    Schmalhofer WA, Bao J, McManus OB, Green B, Matyskiela M, Wunderler D, Bugianesi RM, Felix JP, Hanner M, Linde-Arias AR, Ponte CG, Velasco L, Koo G, Staruch MJ, Miao S, Parsons WH, Rupprecht K, Slaughter RS, Kaczorowski GJ, Garcia ML.
    Biochemistry; 2002 Jun 18; 41(24):7781-94. PubMed ID: 12056910
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR, Arantes EC, Monje F, Stühmer W, Varanda WA.
    Br J Pharmacol; 2003 Jul 18; 139(6):1180-6. PubMed ID: 12871837
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
    Schmitz A, Sankaranarayanan A, Azam P, Schmidt-Lassen K, Homerick D, Hänsel W, Wulff H.
    Mol Pharmacol; 2005 Nov 18; 68(5):1254-70. PubMed ID: 16099841
    [Abstract] [Full Text] [Related]

  • 12. Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
    Suarez-Kurtz G, Vianna-Jorge R, Pereira BF, Garcia ML, Kaczorowski GJ.
    J Pharmacol Exp Ther; 1999 Jun 18; 289(3):1517-22. PubMed ID: 10336547
    [Abstract] [Full Text] [Related]

  • 13. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J, Wulff H, Beeton C, Calabresi PA, Grissmer S, Hänsel W, Chandy KG.
    Mol Pharmacol; 2004 Jun 18; 65(6):1364-74. PubMed ID: 15155830
    [Abstract] [Full Text] [Related]

  • 14. Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.
    Giangiacomo KM, Becker J, Garsky C, Schmalhofer W, Garcia ML, Mullmann TJ.
    Cell Biochem Biophys; 2008 Jun 18; 52(1):47-58. PubMed ID: 18815746
    [Abstract] [Full Text] [Related]

  • 15. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
    Mouhat S, Mosbah A, Visan V, Wulff H, Delepierre M, Darbon H, Grissmer S, De Waard M, Sabatier JM.
    Biochem J; 2004 Jan 01; 377(Pt 1):25-36. PubMed ID: 12962541
    [Abstract] [Full Text] [Related]

  • 16. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
    Yang IC, Scherz MW, Bahinski A, Bennett PB, Murray KT.
    J Pharmacol Exp Ther; 2000 Sep 01; 294(3):955-62. PubMed ID: 10945846
    [Abstract] [Full Text] [Related]

  • 17. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
    Mourre C, Chernova MN, Martin-Eauclaire MF, Bessone R, Jacquet G, Gola M, Alper SL, Crest M.
    J Pharmacol Exp Ther; 1999 Dec 01; 291(3):943-52. PubMed ID: 10565809
    [Abstract] [Full Text] [Related]

  • 18. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
    Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W.
    Circ Res; 2005 Feb 04; 96(2):216-24. PubMed ID: 15618540
    [Abstract] [Full Text] [Related]

  • 19. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.
    Blanc E, Sabatier JM, Kharrat R, Meunier S, el Ayeb M, Van Rietschoten J, Darbon H.
    Proteins; 1997 Nov 04; 29(3):321-33. PubMed ID: 9365987
    [Abstract] [Full Text] [Related]

  • 20. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M, Batista CV, Valdez-Cruz NA, Somodi S, Rodriguez de la Vega RC, Licea AF, Varga Z, Gáspár R, Possani LD, Panyi G.
    Mol Pharmacol; 2005 Apr 04; 67(4):1034-44. PubMed ID: 15615696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.